← FDA DRUG APPROVALS

FDA ANDA · ANDA086837

POLARAMINE

Sponsor: SCHERING

APPLICATION
ANDA086837
TYPE
ANDA
ORIGINAL APPROVAL
1982-07-19
LATEST ACTION
1986-07-24
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Discontinued

Products

POLARAMINEDiscontinued
DEXCHLORPHENIRAMINE MALEATE 2MG/5ML · SYRUP · ORAL

Approval history

1986-07-24Manufacturing (CMC) · Supplement 4AP
1986-07-24Manufacturing (CMC) · Supplement 3AP
1984-05-18Manufacturing (CMC) · Supplement 2AP
1983-03-15Manufacturing (CMC) · Supplement 1AP
1982-07-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →